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ABSTRACT
West Virginia leads the nation in substance abuse deaths per capita. This epidemic has given rise to a novel
population of high-risk, obstetric patients with opiate abuse. Appropriate education, counseling, and implementation of contraception are of extreme importance among this population, due to the risks of unintended
pregnancy. This study was a retrospective chart review to determine compliance and uptake of contraceptive
methods by patients in a maternal buprenorphine maintenance program prior to and following implementation of standardized contraception education and Medicaid coverage of immediate postpartum long-acting
reversible contraceptives (LARC). Rates of planned contraception and rates of actual method initiation were
compared between two groups representing two distinct time periods before and after the intervention.
Rates of highly effective contraception options were noted to significantly increase following dedicated
education and Medicaid coverage (p = 0.04). Patients receiving no contraception at all significantly decreased
following these interventions (p = 0.003). Patients desiring surgical sterilization continued to encounter barriers to care as the rate of actual sterilization to desired sterilization remained low.
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INTRODUCTION
For two consecutive years in 2017 and 2018, West
Virginia had the highest number of overdose deaths
per capita in the United States at 57.8 and 51.5 per
100,000, respectively.1 Among the sizable opioid
abusing population of West Virginia, the obstetric
population has emerged as a high-risk cohort necessitating specialized care during the antepartum and
postpartum periods. An important aspect of their
obstetric care is postpartum contraception management. Long-acting reversible contraceptives (LARC),
such as intrauterine devices (IUDs) and implants, are
the most effective forms of reversible contraception
and do not require user effort to be effective.2 Given
that the rate of unintended pregnancy is estimated
at 86% among opioid-dependent women, the use of
effective contraception for this patient population is
paramount.3 LARC methods are the least expensive
forms of reversible contraception over five years,4 exhibit normal returns of fertility after discontinuation,
have a low rate of complications, and have high rates
of patient satisfaction.5 LARC methods would benefit
these high-risk pregnant women with opiate abuse.
This population faces several unique barriers to
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appropriate contraception management including
compliance, knowledge deficits, and access to care.
It has been previously established that this patient
population has very poor compliance to postpartum
visits, a time when most contraceptive counseling
and implementation occur.6 Additionally, state law
currently mandates that written consent must be
obtained 30 days in advance of any routine delivery
or 72 hours in advance of a preterm delivery for a
sterilization procedure to be covered by Medicaid7;
this stipulation can prevent women with undesired
fertility from pursuing sterilization due to concerns
for out-of-pocket cost. According to the Contraceptive CHOICE project, in the absence of barriers such as
knowledge and cost, the rate of initiation of LARC was
higher than other contraceptive methods. Accessible,
affordable, easy-to-use contraception, such as LARC,
should be a major focus when counseling these highrisk patients.8
The Maternal Addiction and Recovery Center (MARC)
program at our institution provides specialty care
for pregnant women with substance abuse. In a past
study looking at a cohort of women from 2010-2014,
planned and actual contraception were evaluated,
along with compliance with a postpartum visit. This
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study demonstrated poor LARC uptake among
women with substance abuse, poor compliance with
pre-pregnancy desired contraception choices, an increased rate of changing to lower efficacy contraception options, and poor compliance with postpartum
visits.9 Since this study, a standardized contraception
counseling intervention was implemented within the MARC program. This intervention provided
education to MARC patients about all birth control
methods during their antenatal care. Additionally, in
2016, West Virginia Medicaid implemented coverage
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for immediate postpartum (IPP) LARC placement. IPP
LARCs are done immediately after delivery during the
inpatient stay. This practice is thought to reduce barriers and improve compliance with LARC methods.
The purpose of this study was to determine if contraception education provision and IPP LARC access
improved contraception usage among pregnant
women with opiate abuse. Furthermore, it was the
aim of this study to review all contraception choices
and successful initiation of those choices among this
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high-risk obstetric population.
METHODS
This study was a retrospective chart review including
patients enrolled in the MARC program. We defined
the population prior to implementation of any barrier-to-care interventions as those patients actively
enrolled into the MARC program for their obstetric
care from 1/2010-12/2014 (cohort 1), and the population after implementation of interventions as those
patients actively enrolled into the MARC program for
their obstetric care from 1/2016-12/2018 (cohort 2).
The first barrier-to-care intervention was the impleMARSHALL JOURNAL OF
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mentation of a dedicated contraception education
curriculum. The MARC program has a rotating list of
speakers to discuss various topics with the participants. Approximately every 12 weeks, an OBGYN
physician conducted an hour-long formal educational session with MARC participants. This session educated MARC patients on all forms of contraception
including LARC methods and sterilization methods
such as bilateral tubal ligation and vasectomy. The
risks, benefits, bleeding patterns, and procedures of
each method were reviewed with adequate time for
questions and discussion. The second intervention
was new legislation providing Medicaid coverage of
immediate postpartum LARC methods.
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Figure 1: Patients desiring bilateral tubal ligation for contraception vs. patients receiving
BTL. Cohort 1 – 13 (56.5%) vs. Cohort 2 – 43 (55.8%) (p= .95)

Figure 2: Patients desiring LARC for contraception vs. patients receiving LARC. Cohort 1
– 6 (16.7%) vs. Cohort 2 – 27 (60%) (p=.04)

Data collection concluded prior to 2015 to allow for
a full year of follow-up in order to assess the prevalence of short-interval repeat pregnancy. Short-interval repeat pregnancy was defined as pregnancy
within a year of delivery. Data were not collected on
those patients who were pregnant in 2015 to avoid
overlapping the allotted 1 year follow-up period
with the implementation of our interventions in
2016. Prenatal charts were reviewed for planned
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contraception, defined as the contraceptive method
documented antenatally that the patient wanted
following delivery. Charts were also reviewed for
actual contraception, defined as the contraceptive
method the patient actually received following delivery. Patients’ postpartum notes were used to assess
postpartum visit compliance as well as compliance
or successful implementation of contraception
within six weeks of delivery. Short-interval repeat
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pregnancies were evaluated based on return office
visits for a new pregnancy within one year of the
antecedent pregnancy. Demographic data were collected from the prenatal record including age, race,
gravidity, parity, mode of delivery, smoking status,
and history of sexually transmitted diseases. Contraception options were placed into tiers according to
efficacy: Tier 1 – LARC and sterilization methods; Tier
2 – hormonal contraceptives including birth control
pills, ring, and depot medroxyprogesterone; and Tier
3 – barrier methods including condoms/diaphragms,
undecided, or no contraception. Contraceptive use,
follow-up, rapid repeat pregnancy rates, and changes in contraceptive efficacy (from what was planned
to what was actually given) were compared between
groups. Continuous variables were analyzed using a
t-test, and categorical variables were analyzed using
a chi-square or Fisher’s exact test.
RESULTS
There were 61 patients included in cohort 1 and 173
patients included in cohort 2. Upon comparison of
the two groups, the only statistically different demographic value between them was a difference in the
mean age (Table 1; cohort 1 – 26.7 years, SD 5.1; cohort 2 – 28.7 years, SD 4.5; p = 0.003). Of note, there
were 19 patients in cohort 1 who had no documentation of any insurance type or self-pay status who
were not included in that portion of the demographic data. Rates of postpartum visit compliance within
6 weeks were noted to be 32 (52.5%) for cohort 1 and
87 (50.3%) for cohort 2 and did not differ between
the cohorts (p = 0.77) (Table 2). Rates of short-interval repeat pregnancy also did not differ significantly
between the cohorts: 4 (6.6%) in cohort 1 and 10
(5.8%) in cohort 2 (p = 0.83) (Table 2). The rate of
“undecided/none” as a planned method of contraception as documented antepartum significantly
decreased from 23 (37.7%) in cohort 1 to 33 (19.1%)
in cohort 2 (p = 0.003) (Table 3). The “actual contraception initiated” rate for progesterone implant
significantly increased from 0 (0%) in cohort 1 to 19
(11%) in cohort 2 (p = 0.007) (Table 4). The overall
percentage receiving Tier 1 contraception methods
increased significantly from 18 (29.5%) to 83 (48.0%)
(p = 0.012). Of those patients desiring bilateral tubal
ligation for contraception, 13 of the 23 patients in
cohort 1 (56.5%) and 43 of the 77 in cohort 2 (55.8%)
actually received a sterilization procedure (p = .95)
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(Figure 1). Of the 6 patients who desired LARC antepartum, only one patient received LARC in cohort 1
(16.7%) as compared to 27 of the 45 (60%) in cohort
2 (p = 0.04) (Figure 2).
DISCUSSION
At the start of this study, WV Medicaid initiated
reimbursement for immediate postpartum (IPP)
LARC provision, effectively ameliorating two of the
proposed barriers to care facing substance abuse patients: poor compliance with postpartum follow-up
and concern for cost. Prior to 2016, patients desiring
LARC were required to attend postpartum visits to
obtain a contraceptive implant or IUD. Nearly half of
the MARC population (45.9%), regardless of planned
contraception method, received no contraception
postpartum in cohort 1. With the implementation of
rigorous in-office resident-physician counseling and
availability of IPP options, that number decreased to
19.1% in cohort 2. After making IPP LARC available,
significantly more patients from cohort 2 chose LARC
methods antepartum (45%) and actually implemented LARC methods postpartum (n=27, 60% of
expected). This finding is in contrast to other studies
demonstrating low use of LARCs among opioid-addicted patients from 5-13%.10,11 Despite improvements in contraception counseling and implementation of planned contraception, significant loss to
follow-up among MARC patients persisted between
cohorts (52.5% vs. 50.3% [p = 0.77]). This persistent
non-compliance with postpartum visits emphasizes
the importance of antepartum contraception counseling, provision of LARC options prior to leaving
the hospital, and ensuring those patients with
undesired fertility actually receive their sterilization
procedures. The vast majority of patients included in
this trial were Medicaid recipients (92.5%) and were
therefore eligible for IPP LARC options. Regardless of
their antepartum contraception choices, adequate
counseling on the safety, efficacy, ease of use, and
cost coverage of LARC options should be provided to
these patients.
In our study, only 55.8% of MARC patients in cohort
2 received a bilateral tubal ligation when desired;
this is consistent with the rate from cohort 1 (56.5%).
There are multiple proposed reasons for the low
rate of surgical sterilization. West Virginia Medicaid
requires patients to be over 21 years old, to be med-
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ically competent, and to have signed a state bilateral
tubal ligation consent form 30 days in advance but
not more than 180 days in advance of delivery.
There is an emergent delivery/abdominal surgery
clause, however, stating that the time from consent
to the time of delivery/surgery must be 72 hours.
These stringent additional stipulations may deter patients with undesired fertility from pursuing surgical
sterilization. Additionally, operating room availability,
surgeon availability, and anesthesia availability often
preclude immediate post-delivery tubal ligations
which may further contribute to the low rate of completion of desired sterilization procedures.
As a retrospective chart review, the data are limited
by accurate medical records, in this instance resident
clinic antepartum and postpartum documentation. Further limitations included loss-to-follow-up.
Among patients that did not keep postpartum follow-up, it is impossible to determine if they pursued
any form of contraception with another provider or
went on to have a rapid-repeat pregnancy. A final
confounding factor was the introduction and implementation of multiple interventions simultaneously.
It is difficult to distinguish which intervention had a
greater impact upon patient contraception choice:
increased counseling or greater ease of access to
care.
We have documented an increase in postnatal LARC
uptake and reductions in no-contraception as a
planned method of contraception following the
introduction of structured prenatal contraception
education and concurrent Medicaid coverage for
immediate postnatal effective contraception. As
numbers and follow-up increase, we speculate that
these findings will translate into a reduced number
of unintended pregnancies in this vulnerable population. Continued efforts must be made to appropriately educate and counsel the high-risk obstetric
population with substance abuse in West Virginia
regarding contraception options and availability. It is
the responsibility of obstetric providers to continue
to educate patients on the safety, efficacy, and ease
of use related to LARC methods as these methods
become more easily available immediately postpartum. It is also paramount to continue identifying and
rectifying barriers keeping high-risk patients from
the care they deserve.
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